Moderna and Merck expand partnership to develop new cancer vaccines
Patient centricity is a priority for Merck and its Executive Vice President and Head of EMEA Region, Chris Round, outlines what practical steps the company is taking to improve life for patients and carers.
Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono, on the evolution of the Value & Access function.
Funding will go toward expansion of platform capabilities.
Immunotherapy combinations will be the focus – but attention is shifting towards these agents proving their overall survival benefits.